Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
XCUR similar filings
- 9 Mar 21 Departure of Directors or Certain Officers
- 3 Mar 21 Exicure Granted Orphan Drug Designation by the U.S. Food and Drug Administration for Cavrotolimod
- 11 Jan 21 Exicure Granted Two Fast Track Designations for Cavrotolimod (AST-008) from the U.S. Food and Drug Administration
- 7 Jan 21 Regulation FD Disclosure
- 5 Jan 21 Departure of Directors or Certain Officers
- 12 Nov 20 Exicure, Inc. Reports Third Quarter 2020 Financial Results and Corporate Progress
- 1 Oct 20 Entry into a Material Definitive Agreement
Filing view
External links